Cargando…

Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks targeted therapies. Patients with TNBC have a very poor prognosis because the disease often metastasizes. New treatment approaches addressing drivers of metastasis and tumor growth are crucial to impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jihyun, Tacam, Moises J., Chauhan, Gaurav, Cohen, Evan N., Gagliardi, Maria, Iles, Lakesla R., Ueno, Naoto T., Battula, Venkata L., Sohn, Yoo-Kyoung, Wang, Xiaoping, Kim, Hak-Sung, Krishnamurthy, Savitri, Fowlkes, Natalie W., Green, Morgan M., Bartholomeusz, Geoffrey A., Tripathy, Debu, Reuben, James M., Bartholomeusz, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357760/ https://www.ncbi.nlm.nih.gov/pubmed/34241740 http://dx.doi.org/10.1007/s10549-021-06316-2

Ejemplares similares

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
por: Xie, Xuemei, et al.
Publicado: (2023)

Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking
por: Selyunin, Andrey S., et al.
Publicado: (2017)

Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies
por: Eckhardt, Bedrich L., et al.
Publicado: (2018)

PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin
por: Lee, J, et al.
Publicado: (2012)

Expression of histone deacetylase (HDAC) family members in bortezomib-refractory multiple myeloma and modulation by panobinostat
por: Cheng, Tiewei, et al.
Publicado: (2021)

Nonphosphorylatable Src Ser75 Mutation Increases Ethanol Preference and Consumption in Mice
por: Kato, Goro
Publicado: (2019)

Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin
por: Dilruba, Shahana, et al.
Publicado: (2020)

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
por: Gagliardi, Maria, et al.
Publicado: (2020)

Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells
por: Sugimoto, Takeshi, et al.
Publicado: (2007)

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2(+) cancer stem cells
por: Battula, Venkata Lokesh, et al.
Publicado: (2017)

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
por: Lee, Jangsoon, et al.
Publicado: (2015)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
por: Bartholomeusz, Chandra, et al.
Publicado: (2011)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Neurocognitive and Social Cognitive Approaches for Improving Functional Outcome in Early Psychosis: Theoretical Considerations and Current State of Evidence
por: Bartholomeusz, Cali F., et al.
Publicado: (2012)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

Early life programming of pain: focus on neuroimmune to endocrine communication
por: Zouikr, I., et al.
Publicado: (2016)

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
por: Mori, Masamichi, et al.
Publicado: (2017)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

Design, rationale and feasibility of a multidimensional experimental protocol to study early life stress
por: Bartholomeusz, M. Dillwyn, et al.
Publicado: (2017)

A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer
por: Lee, Sae Byul, et al.
Publicado: (2018)

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
por: Hull, Ashleigh, et al.
Publicado: (2020)

Development of [(225)Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration
por: Hull, Ashleigh, et al.
Publicado: (2023)

In vitro characterisation of [(177)Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer
por: Hull, Ashleigh, et al.
Publicado: (2023)

Ink4a/Arf(−/−) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(−) quiescent cells
por: Kai, Kazuharu, et al.
Publicado: (2013)

Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury
por: Hara, Hironori, et al.
Publicado: (2018)

Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
por: García, Ricardo A., et al.
Publicado: (2021)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA?
por: Kirkpatrick, D. Lynn, et al.
Publicado: (2012)

The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy
por: Hull, Ashleigh, et al.
Publicado: (2020)

Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool
por: Krishnamurthy, Savitri, et al.
Publicado: (2023)

Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis
por: Su, Fei, et al.
Publicado: (2020)

Central carbon metabolism in the progression of mammary carcinoma
por: Richardson, Adam D., et al.
Publicado: (2007)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009)

Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice
por: Oostendorp, Roos L., et al.
Publicado: (2010)

Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C
por: Vita, Marina F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fru68c02akhc1t2usrpd5tc6lv